Cargando…

Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis

BACKGROUND: Alfuzosin has been widely used to treat benign prostatic hyperplasia and prostatitis, and is claimed to be a selective agent for the lower urinary tract with low incidence of adverse side-effects and hypotensive changes. Recently, several randomized controlled trials have reported using...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chenli, Zeng, Guohua, Kang, Ran, Wu, Wenqi, Li, Jiasheng, Chen, Kang, Wan, Show P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526635/
https://www.ncbi.nlm.nih.gov/pubmed/26244843
http://dx.doi.org/10.1371/journal.pone.0134589
_version_ 1782384444368224256
author Liu, Chenli
Zeng, Guohua
Kang, Ran
Wu, Wenqi
Li, Jiasheng
Chen, Kang
Wan, Show P.
author_facet Liu, Chenli
Zeng, Guohua
Kang, Ran
Wu, Wenqi
Li, Jiasheng
Chen, Kang
Wan, Show P.
author_sort Liu, Chenli
collection PubMed
description BACKGROUND: Alfuzosin has been widely used to treat benign prostatic hyperplasia and prostatitis, and is claimed to be a selective agent for the lower urinary tract with low incidence of adverse side-effects and hypotensive changes. Recently, several randomized controlled trials have reported using Alfuzosin as an expulsive therapy of ureteral stones. Tamsulosin, another alpha blocker, has also been used as an agent for the expulsive therapy for ureteral stones. It is unclear whether alfuzosin has similar efficacy as Tamsulosin in the management of ureteral stones. OBJECTIVE: To perform a systematic review and analysis of literatures comparing Alfuzosin with Tamsulosin or standard conservative therapy for the treatment of ureteral stones less than 10 mm in diameter. METHODS: A systematic literature review was performed in December 2014 using Pubmed, Embase, and the Cochrane library databases to identify relevant studies. All randomized and controlled trials were included. A subgroup analysis was performed comparing Alfuzosin with control therapy on the management of distal ureteral stones. RESULTS: Alfuzosin provided a significantly higher stone-free rate than the control treatments (RR: 1.85; 95% confidence interval [CI], 1.35–2.55; p<0.001), and a shorter stone expulsion time (Weighted mean difference [WMD]: -4.20 d, 95%CI, -6.19 to -2.21; p<0.001), but it has a higher complication rate (RR: 2.02; 95% CI, 1.30–3.15; p<0.01). When Alfuzosin was compared to Tamsulosin, there was no significant difference in terms of stone-free rate (RR: 0.90; 95% CI, 0.79–1.02; p = 0.09) as well as the stone expulsion time (WMD: 0.52 d, 95%CI, -1.61 to 2.64; p = 0.63). The adverse effects of Alfuzosin were similar to those of Tamsulosin (RR: 0.88; 95% CI, 0.61–1.26; p = 0.47). CONCLUSIONS: Alfuzosin is a safe and effective agent for the expulsive therapy of ureteral stones smaller than 10 mm in size. It is more effective than therapeutic regiment without alpha blocker. It is equivalent to Tamsulosin in its effectiveness and safety profile. Adverse effects should always be kept in mind when use this class of drugs.
format Online
Article
Text
id pubmed-4526635
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45266352015-08-12 Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis Liu, Chenli Zeng, Guohua Kang, Ran Wu, Wenqi Li, Jiasheng Chen, Kang Wan, Show P. PLoS One Research Article BACKGROUND: Alfuzosin has been widely used to treat benign prostatic hyperplasia and prostatitis, and is claimed to be a selective agent for the lower urinary tract with low incidence of adverse side-effects and hypotensive changes. Recently, several randomized controlled trials have reported using Alfuzosin as an expulsive therapy of ureteral stones. Tamsulosin, another alpha blocker, has also been used as an agent for the expulsive therapy for ureteral stones. It is unclear whether alfuzosin has similar efficacy as Tamsulosin in the management of ureteral stones. OBJECTIVE: To perform a systematic review and analysis of literatures comparing Alfuzosin with Tamsulosin or standard conservative therapy for the treatment of ureteral stones less than 10 mm in diameter. METHODS: A systematic literature review was performed in December 2014 using Pubmed, Embase, and the Cochrane library databases to identify relevant studies. All randomized and controlled trials were included. A subgroup analysis was performed comparing Alfuzosin with control therapy on the management of distal ureteral stones. RESULTS: Alfuzosin provided a significantly higher stone-free rate than the control treatments (RR: 1.85; 95% confidence interval [CI], 1.35–2.55; p<0.001), and a shorter stone expulsion time (Weighted mean difference [WMD]: -4.20 d, 95%CI, -6.19 to -2.21; p<0.001), but it has a higher complication rate (RR: 2.02; 95% CI, 1.30–3.15; p<0.01). When Alfuzosin was compared to Tamsulosin, there was no significant difference in terms of stone-free rate (RR: 0.90; 95% CI, 0.79–1.02; p = 0.09) as well as the stone expulsion time (WMD: 0.52 d, 95%CI, -1.61 to 2.64; p = 0.63). The adverse effects of Alfuzosin were similar to those of Tamsulosin (RR: 0.88; 95% CI, 0.61–1.26; p = 0.47). CONCLUSIONS: Alfuzosin is a safe and effective agent for the expulsive therapy of ureteral stones smaller than 10 mm in size. It is more effective than therapeutic regiment without alpha blocker. It is equivalent to Tamsulosin in its effectiveness and safety profile. Adverse effects should always be kept in mind when use this class of drugs. Public Library of Science 2015-08-05 /pmc/articles/PMC4526635/ /pubmed/26244843 http://dx.doi.org/10.1371/journal.pone.0134589 Text en © 2015 Liu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Liu, Chenli
Zeng, Guohua
Kang, Ran
Wu, Wenqi
Li, Jiasheng
Chen, Kang
Wan, Show P.
Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis
title Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis
title_full Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis
title_fullStr Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis
title_full_unstemmed Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis
title_short Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis
title_sort efficacy and safety of alfuzosin as medical expulsive therapy for ureteral stones: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526635/
https://www.ncbi.nlm.nih.gov/pubmed/26244843
http://dx.doi.org/10.1371/journal.pone.0134589
work_keys_str_mv AT liuchenli efficacyandsafetyofalfuzosinasmedicalexpulsivetherapyforureteralstonesasystematicreviewandmetaanalysis
AT zengguohua efficacyandsafetyofalfuzosinasmedicalexpulsivetherapyforureteralstonesasystematicreviewandmetaanalysis
AT kangran efficacyandsafetyofalfuzosinasmedicalexpulsivetherapyforureteralstonesasystematicreviewandmetaanalysis
AT wuwenqi efficacyandsafetyofalfuzosinasmedicalexpulsivetherapyforureteralstonesasystematicreviewandmetaanalysis
AT lijiasheng efficacyandsafetyofalfuzosinasmedicalexpulsivetherapyforureteralstonesasystematicreviewandmetaanalysis
AT chenkang efficacyandsafetyofalfuzosinasmedicalexpulsivetherapyforureteralstonesasystematicreviewandmetaanalysis
AT wanshowp efficacyandsafetyofalfuzosinasmedicalexpulsivetherapyforureteralstonesasystematicreviewandmetaanalysis